뒤로
Qyuns Therapeutics Co., Ltd.(02509.HK) 가격
02509.HK 주가 차트
QYUNS-B (02509.HK)
Qyuns Therapeutics Co., Ltd.
HK$19.55
-3.02%
$-0.6
장 종료: Feb 06, 16:00:00 HKT
아직 데이터 없음Earnings FAQ
02509.HK의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Qyuns Therapeutics Co., Ltd. 02509.HK의 지난 분기 매출 실적은 어땠나요?
Qyuns Therapeutics Co., Ltd.의 매출 추정치는 얼마인가요?
Qyuns Therapeutics Co., Ltd.의 수익 품질 점수는 얼마인가요?
Qyuns Therapeutics Co., Ltd.는 언제 수익을 보고하나요?
Qyuns Therapeutics Co., Ltd.의 예상 수익은 얼마인가요?
Qyuns Therapeutics Co., Ltd.은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$20.14
시가
$20.16
일일 범위
$19.55 - $20.46
52주 범위
$5.95 - $36.5
거래량
127.2K
평균 거래량
507.1K
EPS(TTM)
-0.97
배당수익률
--
시가총액
$4.4B
QYUNS-B란 무엇인가요?
Qyuns Therapeutics Co., Ltd. is a clinical biopharmaceutical company focusing on biotherapeutics for autoimmune and allergic diseases. The company is headquartered in Taizhou, Jiangsu and currently employs 337 full-time employees. The company went IPO on 2024-03-20. The firm is mainly engaged in biotechnology research and development of biological therapies for autoimmune and allergic diseases. The firm's business mainly covers four major disease areas, including skin, rheumatism, respiratory and digestive tract diseases. The firm is developing eight projects, with target indications including psoriasis, atopic dermatitis, rheumatoid arthritis, inflammatory bowel disease and asthma. The firm's core products include QX002N and QX005N.